We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
GRF-P.MC

Price
5.91
Stock movement up
+0.01 (0.17%)
Company name
Grifols SA
Exchange
(MC
,
Currency
EUR
)
Sector
Other >
Other
Market cap
-
Ent value
11.88B
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
5.05
PEG
-
EPS growth
-36.83%
1 year return
-3.90%
3 year return
-16.98%
5 year return
-20.30%
10 year return
-1.77%
Last updated: 2025-04-12

DIVIDENDS

GRF-P.MC does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales1.74

FINANCIALS

Per share

Loading...
Per share data
Current share count-
EPS (TTM)0.27
FCF per share (TTM)-0.34

Income statement

Loading...
Income statement data
Revenue (TTM)6.85B
Gross profit (TTM)2.61B
Operating income (TTM)837.78M
Net income (TTM)182.42M
EPS (TTM)0.27
EPS (1y forward)1.17

Margins

Loading...
Margins data
Gross margin (TTM)38.12%
Operating margin (TTM)12.23%
Profit margin (TTM)2.66%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.11B
Net receivables752.98M
Total current assets6.91B
Goodwill7.10B
Intangible assets2.88B
Property, plant and equipment6.68B
Total assets22.29B
Accounts payable877.72M
Short/Current long term debt0.00
Total current liabilities4.11B
Total liabilities14.00B
Shareholder's equity8.30B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-103.73M
Capital expenditures (TTM)126.08M
Free cash flow (TTM)-229.81M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity2.20%
Return on Assets0.82%
Return on Invested Capital1.20%
Cash Return on Invested Capital-1.51%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open6.01
Daily high6.08
Daily low5.86
Daily Volume195K
All-time high23.65
1y analyst estimate21.32
Beta-
EPS (TTM)0.27
Dividend per share-
Ex-div date3 Jun 2021
Next earnings date12 May 2025

Downside potential

Loading...
Downside potential data
GRF-P.MCS&P500
Current price drop from All-time high-75.01%-12.89%
Highest price drop-79.14%-56.47%
Date of highest drop7 Mar 20249 Mar 2009
Avg drop from high-26.62%-11.07%
Avg time to new high22 days12 days
Max time to new high1317 days1805 days
COMPANY DETAILS
GRF-P.MC (Grifols SA) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Employees
Website
Investor relations
-
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
In recent weeks, European markets have experienced significant turbulence, with the pan-European STOXX Europe 600 Index dropping 8.44%, marking its steepest decline in five years amid heightened globa...
April 8, 2025
As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and in...
March 10, 2025
As global markets navigate a volatile start to 2025, with the Federal Reserve holding rates steady and AI competition shaking up the tech sector, investors are closely watching how these dynamics impa...
February 7, 2025
‘Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms appear, leading to new diagnostic tools and disease-mod...
January 14, 2025
As global markets navigate a mixed economic landscape marked by declining consumer confidence and fluctuating indices, technology stocks continue to capture attention with their potential for high gro...
January 2, 2025
As global markets reach new heights, with indices like the Russell 2000 hitting record intraday highs, investor sentiment remains buoyed by domestic policy developments and easing geopolitical tension...
December 4, 2024
GIGA-2339 contains more than 1,000 fully human recombinant anti-HBV antibodies and is the first recombinant polyclonal therapeutic in development to treat and functionally cure chronic HBV infectionSA...
November 19, 2024
As global markets react to rising U.S. Treasury yields and a tempered outlook for Federal Reserve rate cuts, small-cap stocks have felt the pressure more acutely than their large-cap counterparts. In ...
November 1, 2024
As global markets grapple with rising Treasury yields and tepid economic growth, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In this envir...
October 31, 2024
Grifols (GRFS) announced that its plasma-protein based fibrin sealant, FS, for controlling surgical bleeding has received approval from the United States Food and Drug Administration, FDA, for pediatr...
October 30, 2024
Next page